Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parsons

Showing results (231-240 of 712) with videos related to

Pageof 72
Sort By:
Neuropharmacology|May 1, 1995
Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneityI Bresink, W Danysz, C G Parsons, et al.
Pigment Cell Research|February 1, 1993
In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblastsJ A Thomson, P G Parsons, R A Sturm
Frontiers in Behavioral Neuroscience|August 27, 2010
Regulation of extinction-related plasticity by opioid receptors in the ventrolateral periaqueductal gray matterRyan G Parsons, Georgette M Gafford, Fred J Helmstetter
Pain|March 29, 2001
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake ratsAndrea K Houghton, Chris G Parsons, Max P Headley
Melanoma Research|December 1, 1994
Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligandsG Le Gros, X M Zhang, P G Parsons
Prostaglandins|August 1, 1989
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acidJ D Morrow, W G Parsons, L J Roberts
Biochemical Pharmacology|November 15, 1986
Selective toxicity of deoxyadenosine analogues in human melanoma cell linesP G Parsons, E P Bowman, R L Blakley
Learning & Memory (Cold Spring Harbor, N.Y.)|December 3, 2005
Effects of post-training hippocampal injections of midazolam on fear conditioningGeorgette M Gafford, Ryan G Parsons, Fred J Helmstetter
European Journal of Cancer & Clinical Oncology|June 1, 1988
Sensitivity of human neuroblastoma to activated dacarbazine: relationships between cell survival, methyltransferase activity and activation of adenovirus-5M G Lihou, P J Smith, P G Parsons
Neuropharmacology|July 1, 1997
Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTPW Zajaczkowski, T Frankiewicz, C G Parsons, et al.
Pageof 72

Showing results (231-240 of 712) with videos related to

Sort By:
Pageof 72
Neuropharmacology|May 1, 1995
Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneityI Bresink, W Danysz, C G Parsons, et al.
Pigment Cell Research|February 1, 1993
In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblastsJ A Thomson, P G Parsons, R A Sturm
Frontiers in Behavioral Neuroscience|August 27, 2010
Regulation of extinction-related plasticity by opioid receptors in the ventrolateral periaqueductal gray matterRyan G Parsons, Georgette M Gafford, Fred J Helmstetter
Pain|March 29, 2001
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake ratsAndrea K Houghton, Chris G Parsons, Max P Headley
Melanoma Research|December 1, 1994
Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligandsG Le Gros, X M Zhang, P G Parsons
Prostaglandins|August 1, 1989
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acidJ D Morrow, W G Parsons, L J Roberts
Biochemical Pharmacology|November 15, 1986
Selective toxicity of deoxyadenosine analogues in human melanoma cell linesP G Parsons, E P Bowman, R L Blakley
Learning & Memory (Cold Spring Harbor, N.Y.)|December 3, 2005
Effects of post-training hippocampal injections of midazolam on fear conditioningGeorgette M Gafford, Ryan G Parsons, Fred J Helmstetter
European Journal of Cancer & Clinical Oncology|June 1, 1988
Sensitivity of human neuroblastoma to activated dacarbazine: relationships between cell survival, methyltransferase activity and activation of adenovirus-5M G Lihou, P J Smith, P G Parsons
Neuropharmacology|July 1, 1997
Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTPW Zajaczkowski, T Frankiewicz, C G Parsons, et al.
Pageof 72